Showing results (131-140 of 310) with videos related to

Sort By:
Pageof 31
Ophthalmology Science|July 1, 2026
Assessing Polypoidal Choroidal Vasculopathy-Related OCT Features in the TENAYA and LUCERNE TrialsKelvin Yi Chong Teo, Philippe Margaron, Timothy Y Y Lai, et al.
Ophthalmology and Therapy|July 1, 2026
Advances in Polypoidal Choroidal Vasculopathy (PCV) Management: Emerging Evidence for Faricimab and Aflibercept 8 mgMohamed Zakaria Sherif, Kelvin Y C Teo, Timothy Y Y Lai, et al.
Ophthalmology|May 28, 2013
Refractive errors and age-related macular degeneration: a systematic review and meta-analysisChen-Wei Pan, M Kamran Ikram, Carol Y Cheung, et al.
Ophthalmology. Retina|February 21, 2021
Patterns and Characteristics of a Clinical Implementation of a Self-Monitoring Program for Retina Diseases during the COVID-19 PandemicKelvin Yi Chong Teo, Lucas M Bachmann, Dawn Sim, et al.
Acta Ophthalmologica|June 26, 2015
Relationship of ocular and systemic factors to the visibility of choroidal-scleral interface using spectral domain optical coherence tomographyPreeti Gupta, Ching-Yu Cheng, Chui Ming Gemmy Cheung, et al.
Investigative Ophthalmology & Visual Science|June 28, 2014
Ethnic variation in early age-related macular degeneration lesions between white Australians and Singaporean AsiansNichole Joachim, Paul Mitchell, Christine Younan, et al.
American Journal of Ophthalmology|March 9, 2019
Efficacy and Safety of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy: Two-Year Results of the Aflibercept in Polypoidal Choroidal Vasculopathy StudyTien Yin Wong, Yuichiro Ogura, Won Ki Lee, et al.
Journal of Diabetes|April 5, 2016
HbA1c, systolic blood pressure variability and diabetic retinopathy in Asian type 2 diabeticsValencia Foo, Joanne Quah, Gemmy Cheung, et al.
The British Journal of Ophthalmology|April 16, 2025
Vision-related quality of life impact of age-related macular degeneration in older adults aged 60-100 years: a cross-sectional studyTai Anh Vu, Eva K Fenwick, Ryan E K Man, et al.
Clinical Ophthalmology (Auckland, N.Z.)|July 2, 2026
Discontinuing Anti-VEGF Therapy in Patients with Neovascular Age-Related Macular Degeneration That Remains Inactive with Treatment at the Maximum Injection IntervalGünhal Şatırtav, Monica Karin Lövestam-Adrian, Woohyok Chang, et al.
Pageof 31